SillaJen, Inc.   Report issue

For profit Phase 1 Phase 2 Phase 3
Founded: San Francisco CA United States (2003)

Organization Overview

First Clinical Trial
2015
NCT02562755
First Marketed Drug
None
First NDA Approval
None
Last Known Activity
2018

Timeline

NOW
  • Now

Mergers & Acquisitions

Historical Acquisition Tree

Alternative names

SillaJen Biotherapeutics, Inc. | SillaJen, Inc.